Bowel perforation in non-small cell lung cancer after bevacizumab therapy.

Bowel perforation in non-small cell lung cancer after bevacizumab therapy.

Item
http://www.wikidata.org/entity/Q34594867
Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancerRisk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study.Bowel perforation after erlotinib treatment in a patient with non-small cell lung cancer.Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusionSmall bowel perforation secondary to metastatic non-small cell lung cancer. A rare entity with a dismal prognosis.Colitis associated with biological agentsExtensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature.Case report of perforation of an ileal neobladder after treatment of rectal cancer with bevacizumab and comment on mechanisms of intestinal perforation associated with bevacizumab.Late anastomotic breakdown with bevacizumab in colorectal cancers, a case-based review.First description of an uterine perforation potentially imputable to treatment with bevacizumab.Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.
P2860

Bowel perforation in non-small cell lung cancer after bevacizumab therapy.

Item
http://www.wikidata.org/entity/Q34594867
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@ast
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@en
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@nl
type
label
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@ast
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@en
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@nl
prefLabel
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@ast
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@en
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Bowel perforation in non-small cell lung cancer after bevacizumab therapy.
@en
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921